Holderness Investments Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.6M | Hold |
10,458
| – | – | 0.32% | 73 |
|
|
2025
Q4 | $1.44M | Sell |
10,458
-105
| -1% | -$13.8K | 0.29% | 69 |
|
|
2025
Q3 | $1.35M | Sell |
10,563
-964
| -8% | -$118K | 0.28% | 74 |
|
|
2025
Q2 | $1.39M | Buy |
11,527
+145
| +1% | +$16.3K | 0.3% | 74 |
|
|
2025
Q1 | $1.27M | Buy |
11,382
+376
| +3% | +$40K | 0.3% | 79 |
|
|
2024
Q4 | $1.07M | Buy |
11,006
+392
| +4% | +$41.8K | 0.24% | 91 |
|
|
2024
Q3 | $1.22M | Buy |
10,614
+786
| +8% | +$89.2K | 0.27% | 87 |
|
|
2024
Q2 | $1.05M | Buy |
9,828
+673
| +7% | +$67.6K | 0.25% | 89 |
|
|
2024
Q1 | $886K | Sell |
9,155
-125
| -1% | -$12.8K | 0.22% | 104 |
|
|
2023
Q4 | $937K | Hold |
9,280
| – | – | 0.26% | 91 |
|
|
2023
Q3 | $945K | Sell |
9,280
-25
| -0.3% | -$2.54K | 0.37% | 69 |
|
|
2023
Q2 | $939K | Buy |
9,305
+310
| +3% | +$31K | 0.35% | 73 |
|
|
2023
Q1 | $828K | Buy |
8,995
+168
| +2% | +$14.7K | 0.33% | 77 |
|
|
2022
Q4 | $801K | Buy |
8,827
+75
| +0.9% | +$6.32K | 0.35% | 75 |
|
|
2022
Q3 | $665K | Buy |
8,752
+160
| +2% | +$13.3K | 0.3% | 86 |
|
|
2022
Q2 | $726K | Sell |
8,592
-2,229
| -21% | -$196K | 0.3% | 86 |
|
|
2022
Q1 | $950K | Buy |
10,821
+426
| +4% | +$36.9K | 0.32% | 78 |
|
|
2021
Q4 | $909K | Buy |
10,395
+403
| +4% | +$33.5K | 0.27% | 95 |
|
|
2021
Q3 | $817K | Buy |
9,992
+336
| +3% | +$30.2K | 0.27% | 99 |
|
|
2021
Q2 | $881K | Buy |
9,656
+1,330
| +16% | +$118K | 0.29% | 93 |
|
|
2021
Q1 | $712K | Buy |
8,326
+19
| +0.2% | +$1.71K | 0.26% | 101 |
|
|
2020
Q4 | $784K | Sell |
8,307
-130
| -2% | -$11.4K | 0.3% | 87 |
|
|
2020
Q3 | $734K | Hold |
8,437
| – | – | 0.3% | 86 |
|
|
2020
Q2 | $737K | Buy |
8,437
+3,156
| +60% | +$272K | 0.33% | 77 |
|
|
2020
Q1 | $435K | Buy |
5,281
+552
| +12% | +$49.3K | 0.25% | 96 |
|
|
2019
Q4 | $448K | Hold |
4,729
| – | – | 0.19% | 122 |
|
|
2019
Q3 | $411K | Sell |
4,729
-112
| -2% | -$10.1K | 0.19% | 121 |
|
|
2019
Q2 | $442K | Sell |
4,841
-521
| -10% | -$44.1K | 0.2% | 123 |
|
|
2019
Q1 | $462K | Sell |
5,362
-101
| -2% | -$8.11K | 0.22% | 110 |
|
|
2018
Q4 | $420K | Buy |
5,463
+1,202
| +28% | +$93.6K | 0.23% | 104 |
|
|
2018
Q3 | $329K | Buy |
4,261
+875
| +26% | +$64.7K | 0.15% | 150 |
|
|
2018
Q2 | $229K | Buy |
3,386
+145
| +4% | +$10K | 0.11% | 175 |
|
|
2018
Q1 | $235K | Sell |
3,241
-390
| -11% | -$29.7K | 0.12% | 175 |
|
|
2017
Q4 | $273K | Hold |
3,631
| – | – | 0.13% | 163 |
|
|
2017
Q3 | $279K | Sell |
3,631
-196
| -5% | -$14.8K | 0.15% | 160 |
|
|
2017
Q2 | $286K | Buy |
3,827
+196
| +5% | +$13.9K | 0.15% | 156 |
|
|
2017
Q1 | $242K | Buy |
3,631
+195
| +6% | +$13K | 0.12% | 176 |
|
|
2016
Q4 | $224K | Buy |
3,436
+279
| +9% | +$18.1K | 0.2% | 110 |
|
|
2016
Q3 | $223K | Hold |
3,157
| – | – | 0.22% | 106 |
|
|
2016
Q2 | $233K | Sell |
3,157
-238
| -7% | -$16.4K | 0.23% | 107 |
|
|
2016
Q1 | $220K | Buy |
3,395
+76
| +2% | +$5.17K | 0.21% | 113 |
|
|
2015
Q4 | $256K | Buy |
3,319
+123
| +4% | +$9.77K | 0.25% | 106 |
|
|
2015
Q3 | $263K | Buy |
3,196
+385
| +14% | +$34.3K | 0.28% | 99 |
|
|
2015
Q2 | $248K | Hold |
2,811
| – | – | 0.25% | 101 |
|
|
2015
Q1 | $248K | Hold |
2,811
| – | – | 0.25% | 105 |
|
|
2014
Q4 | $233K | Buy |
+2,811
| New | +$233K | 0.24% | 111 |
|
Other funds holding NVS
Holderness Investments Company's NVS Position: Q1 2026 in Review
Holderness Investments Company held its Novartis (NVS) position steady in Q1 2026 at 10,458 shares worth $1.6M. The position accounts for 0.32% of the portfolio, ranked #73.
Holderness Investments Company first reported a position in NVS in Q4 2014 and has held it in 46 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Holderness Investments Company held 10,458 shares of Novartis worth $1.6M as of Q1 2026.
- Holderness Investments Company left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.32% of Holderness Investments Company's portfolio in Q1 2026, its #73 holding.
- Holderness Investments Company first reported a position in Novartis in Q4 2014 and has held it in 46 quarters since.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.